Diagnostics & Tools May 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Diagnostics & Tools industry totaled six mergers & acquisitions and twenty-six financings during the month of May
• In terms of M&A, Diagnostic Services was the most active this month, with 3 transactions; while in terms of financing, In Vitro Diagnostics was the most active, with 10 financings
• Total disclosed M&A value was $28.0 million, while financing totaled $507.9 million
• The largest disclosed M&A transaction this month was the $28.0 million acquisition of Nuclear Healthcare by an undisclosed buyer, while the largest financing was $200 million raised by Tempus Labs
• M&A and financings in the United States accounted for 67% and 52% of total transactions this month, up 47% and 30%, respectively
• Crosstree acted as the financial adviser to Genstar on its acquisition of Advarra